Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains
US12139525B2 · kind B2 · utility
0Cited by
46References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2021 |
| Grant date | Nov 12, 2024 |
| Priority date | — |
| Expiry date | Aug 11, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a novel targeted heterodimeric Fc fusion proteins comprising an IL-15/IL-15Rα Fc fusion protein and an antigen binding domain Fc fusion proteins. In some instances, the antigen binding domain binds to CD8, NKG2A, or NKG2D.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.